Delivery Order SPE2DB20D6037-SPE2DB25FTUJ7
Award Date
1/9/25
Potential Completion Date
1/10/25
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,448, is for the delivery of 100 units of 20 milligram Vyvanse capsules. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC covers a wide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of 4,565,166,332 units of the prescription medication Vyvanse 10 mg capsules. The order has a ceiling value of $1,293.00 and an ultimate completion date of July 17, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, which has a total...
This is a firm fixed-price delivery order for $1,328.40 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order is for the supply of 4565583680 units of Vyvanse 40 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a broad range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,724 contract is for the delivery of 100 capsules of the medication Vyvanse (70 mg) with an ultimate completion date of December 4, 2023.
DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
This is a firm fixed-price delivery order (SPE2DB20D6037|SPE2DB24FTVC9) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,724.00 award is for the supply of 4,564,218,067 units of the prescription drug VYVANSE 10 MG CAPSULE 100S. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,119.08 award is for the delivery of 100 units of the prescription drug Vyvanse 40 mg capsules. The order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides a wide range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of 4,563,918 units of the pharmaceutical drug Vyvanse 20 mg capsules. The firm fixed-price contract is valued at $1,031.85 and has a period of performance through March 11, 2024.
The award is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB24D2106 with DLA, which has a total ceiling value of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,293.00, is for the delivery of 4,565,128,246 units of the prescription drug Vyvanse 20 mg capsules. The award is part of DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $18,459.75 firm fixed-price contract is for the delivery of Vyvanse 40 mg capsules, a specialized prescription medication. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which enables the agency...
This federal contract award, valued at $2,616.04, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of 4,564,544,090 units of the prescription drug Vyvanse 50 mg capsules. The contract is a firm fixed-price delivery order with a completion date of May 9, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...